A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity
暂无分享,去创建一个
Kazuhide Yamamoto | H. Kato | K. Tsutsumi | Naoki Yamamoto | I. Sakakihara | Y. Noma | R. Harada | M. Fujii | H. Kawamoto | T. Ogawa | E. Ishida | K. Hirao | N. Kurihara | O. Mizuno | Yasuhiro Noma | Masakuni Fujii | Osamu Mizuno | Hironari Kato | Naoko Kurihara